Skip to content

The study to see effect of Punarnavadi churna over Ajmodadi Churna in the management of Aamvata with reference to Rheumatoid Arthritis

A randomized controlled clinical study of efficacy of Punarnavadi Churna and Ajmodadi Churna in the management of Aamvata W.S.R to Rheumatoid Arthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080860
Enrollment
60
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

DrVJD Gramin Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1-Patients willing for clinical trial 2-Patients having sign and symptoms of Aamvata 3-The patients age group 20 to 60 years 4-Patients will be selected irrespective of sex and religion 5-RA test positive patients

Exclusion criteria

Exclusion criteria: 1-Patients not willing for clinical trial 2-Patients age not less than 20 years and more than 60 years 3-Chronicity more than 5 years 4-Any severe deformity 5-Pregnant women, Lactating mothers 6-Any major illness like HIV,AIDS,TB,HTN,DM and other malignancy

Design outcomes

Primary

MeasureTime frame
Symptoms like-1.Sandhishool Pain 2.Sandhishoth Inflammation 3.Sandhistabdhata 4.Sandhi sparshasahatva will be decreased and control over Aamvata with reference to Rheumatoid Arthritis.Timepoint: 15 days,30 days,45 days,after starting the treatment

Secondary

MeasureTime frame
Decrease in symptoms of Aamvata and control over RA value.Timepoint: 18 months

Countries

India

Contacts

Public ContactDr Jayashree Katole

Dr.VJD Gramin Ayurved Mahavidyalaya

drjrkatole@gmail.com9423847608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026